Apogee Therapeutics, Inc. Debt Securities, Available-for-sale
Apogee Therapeutics, Inc. (APGE) had Debt Securities, Available-for-sale of $330.74 million as of 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2024-05-13
- 2024-03-31: Debt Securities, Available-for-sale $330.74M.
- 2023-12-31: Debt Securities, Available-for-sale $277.14M.
- 2023-09-30: Debt Securities, Available-for-sale $294.28M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-03-31 | $330.74M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $277.14M 10-Q · filed 2024-05-13 |
| 2023-09-30 | $294.28M 10-Q · filed 2023-11-13 |